After nearly 10 years of follow-up , patients with type 2 diabetes who had been randomly assigned to intensive glucose control for 5.6 years had 8.6 fewer major cardiovascular events per 1000 person-years than those assigned to standard therapy , but no improvement was seen in the rate of overall survival .